Chapter 19 The kallikrein-kinin-kininogen system

Barnes, 1992, Bradykinin and asthma, Thorax, 47, 979, 10.1136/thx.47.11.979 Berry, 1989, A gene for high urinary kallikrein may protect against hypertension in Utah kindreds, Hypertension, 13, 3, 10.1161/01.HYP.13.1.3 Bhoola, 1992, Bioregulation of kinins: kallikreins, kininogens, and kininases, Pharmacol. Revs., 44, 1 Calixto, 1991, Nonpeptide bradykinin antagonist, 97 Carmines, 1990, Control of the renal microvasculature by vasoactive peptides, FASEB J., 4, 3300, 10.1096/fasebj.4.15.2147667 Cheronis, 1992, A new class of bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers, J. Med. Chem., 35, 1563, 10.1021/jm00087a010 Colman, 1989, Contact systems in infectious disease, Revs. Infect. Dis., 11, S689, 10.1093/clinids/11.Supplement_4.S689 Cumming, 1992, Hemodynamic, renal, and hormonal actions of aprotinin in an ovine model of septic shock, Crit. Care Med., 20, 1134, 10.1097/00003246-199208000-00012 Damas, 1992, Influence of a long-acting bradykinin antagonist, Hoe 140, on some acute inflammatory reactions in the rat, Eur. J. Pharmacol., 211, 81, 10.1016/0014-2999(92)90266-7 Denning, 1991, Polarized distribution of bradykinin receptors on airway epithelial cells and independent coupling to second messenger pathways, J. Biol. Chem., 266, 12932, 10.1016/S0021-9258(18)98784-3 Dray, 1993, Inflammation and hypealgesia: highlighting the team effort, Tr. Pharmacol. Sci., 14, 287, 10.1016/0165-6147(93)90041-H Dray, 1993, Bradykinin and inflammatory pain, Tr. Neurosci., 16, 99, 10.1016/0166-2236(93)90133-7 Erdös, 1990, Some old and some new ideas on kinin metabolism, J. Card. Pharmacol., 15, S20, 10.1097/00005344-199015061-00005 Ewald, 1989, Differential G protein-mediated coupling of neurotransmitter receptors to Ca2+ channels in rat dorsal root ganglion neurons in vitro, Neuron, 2, 1185, 10.1016/0896-6273(89)90185-2 Farmer, 1991, Role of kinins in airway diseases, Immunopharmacology, 22, 1, 10.1016/0162-3109(91)90051-Y Farmer, 1989, Evidence for a pulmonary B3 bradykinin receptor, Molec. Pharmacol., 36, 1 Francel, 1992, Bradykinin and neuronal injury, J. Neurotrauma, 9, S27 Gailani, 1991, Factor XI activation in a revised model of blood coagulation, Science, 253, 909, 10.1126/science.1652157 Gutowski, 1991, Antibodies to the αq subfamily of guanine nucleotide-binding regulatory protein α subunits attenuate activation of phosphatidylinositol 4,5-bisphosphate hydrolysis by hormones, J. Biol. Chem., 266, 20519, 10.1016/S0021-9258(18)54955-3 Hall, 1992, Bradykinin receptors: Pharmacological properties and biological roles, Pharmac. Ther., 56, 131, 10.1016/0163-7258(92)90016-S Hess, 1992, Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor, Biochem. Biophys. Res. Comm., 184, 260, 10.1016/0006-291X(92)91187-U Hock, 1991, Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies, Br. J. Pharmacol., 102, 769, 10.1111/j.1476-5381.1991.tb12248.x Kaplan, 1987, The coagulation-kinin pathway of human plasma, Blood, 70, 1, 10.1182/blood.V70.1.1.1 Linz, 1992, Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors, J. Card. Pharmacol., 20, S83, 10.1097/00005344-199200209-00015 Madeddu, 1993, Chronic kinin receptor blockade induces hypertension in deoxycorticosterone-treated rats, Br. J. Pharmacol., 108, 651, 10.1111/j.1476-5381.1993.tb12856.x Margolius, 1995, Kallikreins and kinins. Some unanswered questions about system characteristics and roles in human disease, Hypertension, 26, 221, 10.1161/01.HYP.26.2.221 Müller-Esterl, 1986, Kininogens revisited, Tr. Biochem. Sci., 11, 336, 10.1016/0968-0004(86)90293-8 Proud, 1988, Kinin formation: mechanisms and role in inflammatory disorders, Ann. Rev. Immunol., 6, 49, 10.1146/annurev.iy.06.040188.000405 Salvino, 1993, Design of Potent Non-Peptide Competitive Antagonists of the Human Bradykinin-B2 Receptor, J. Med. Chem., 36, 2583, 10.1021/jm00069a021 Schmaier, 1992, Modulation of the cell membrane expression of the kininogens regulates the rate of bradykinin delivery to cells, Trends Cardiovasc. Med., 2, 108, 10.1016/1050-1738(92)90015-K Seidah, 1989, The cDNA structure of rat plasma kallikrein, DNA, 8, 563, 10.1089/dna.1989.8.563 Steranka, 1988, Bradykinin as a pain mediator: Receptors are localized to sensory neurons, and antagonists have analgesic actions, Proc. Natl. Acad. Sci. USA, 85, 3245, 10.1073/pnas.85.9.3245 Vavrek, 1985, Competitive antagonists of bradykinin, Peptides, 6, 161, 10.1016/0196-9781(85)90033-6 Wachtfogel, 1993, Structural biology, cellular interactions and pathophysiology of the contact system, Thrombosis Research, 72, 1, 10.1016/0049-3848(93)90168-N Whalley, 1992, A novel potent bis(succinimido)hexane peptide heterodimer antagonist (CP-0364) of bradykinin BK1 and BK2 receptors: in vitro and in vivo studies, Br. J. Pharmac., 107, 257 Wilson, 1989, D-Arg-[Hyp3-D-Phe7]-bradykinin, a bradykinin antagonist, reduces mortality in a rat model of endotoxic shock, Circ. Shock, 27, 93 Wirth, 1991, Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies, Br. J. Pharmacol., 102, 774, 10.1111/j.1476-5381.1991.tb12249.x Bhoola, 1992, Bioregulation of kinins: kallikreins, kininogens, and kininases, Pharmacol. Revs., 44, 1